Ofloxacine Almus (Ofloxacin)

Ofloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition prevents the resealing of DNA strands, leading to bacterial cell death and a bactericidal outcome against susceptible pathogens.

The dosage of Ofloxacine Almus is determined by the prescribing clinician based on the type and severity of the infection, patient age, renal function and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Ofloxacin is classified as a pregnancy‑category C drug. It should be used during pregnancy or lactation only when the potential benefits justify the potential risks to the fetus or infant. The prescriber will evaluate the individual situation before deciding on therapy.

To order Ofloxacine Almus, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Ofloxacine Almus (ofloxacin) shares the class‑wide mechanism of DNA gyrase inhibition with other fluoroquinolones but differs in its spectrum of activity, pharmacokinetic profile and dosing convenience. Compared with ciprofloxacin, ofloxacin often offers a broader gram‑positive coverage and may be preferred for certain urinary and respiratory infections, while safety considerations such as tendon‑rupture risk remain similar across the class.

Store Ofloxacine Almus at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Ofloxacine Almus is administered orally as a tablet, taken with a full glass of water. It may be taken with or without food, but if antacids are used, they should be spaced at least two hours apart to avoid reduced absorption.

Serious adverse events associated with ofloxacin include tendon rupture (especially Achilles tendon), QT interval prolongation leading to arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, hepatic dysfunction, and peripheral neuropathy. Patients should seek immediate medical attention if they experience sudden tendon pain, palpitations, severe rash or persistent diarrhea.

Ofloxacine Almus should be avoided in patients with a known hypersensitivity to fluoroquinolones, a history of tendon disorders related to fluoroquinolone use, uncontrolled arrhythmias or prolonged QT interval, and in those receiving concomitant therapy that markedly increases the risk of tendon injury, such as systemic corticosteroids, without careful monitoring.